EarningsQ4 2025 Earnings Report

ANI Pharmaceuticals (BSFA) Q4 2025 Earnings Report

0 Followers

DE:BSFA Q4 2025 EPS Results

Actual EPS€2.08

Consensus EPS€1.78

Beat/MissBeat by +€0.30

One Year Ago EPS€1.45

Actual Revenue€220.50M

Expected Revenue€206.25M

Beat/MissBeat by +€14.26M

YoY Revenue Growth+29.64%

QuarterQ4 2025

Date03/03/2026

TimeBefore Open

Conference CallTuesday, March 3, 2026

DE:BSFA Upcoming Earnings

ANI Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

DE:BSFA Q4 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	1.95 / -	1.821	―
Aug 07, 2026	2026 (Q2)	1.82 / 1.97	1.607	22.78% (+0.37)
May 08, 2026	2026 (Q1)	1.16 / 1.83	1.517	20.59% (+0.31)
Mar 03, 2026	2025 (Q4)	1.78 / 2.08	1.455	42.94% (+0.62)
Nov 10, 2025	2025 (Q3)	1.58 / 1.82	1.196	52.24% (+0.62)
Aug 08, 2025	2025 (Q2)	1.25 / 1.61	0.91	76.47% (+0.70)
May 09, 2025	2025 (Q1)	1.23 / 1.52	1.08	40.50% (+0.44)
Feb 28, 2025	2024 (Q4)	1.28 / 1.45	0.893	63.00% (+0.56)
Nov 08, 2024	2024 (Q3)	0.97 / 1.20	1.133	5.51% (+0.06)
Aug 06, 2024	2024 (Q2)	0.85 / 0.91	1.142	-20.31% (-0.23)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed